secwatch.observer — SEC 8-K summary
======================================

Issuer:     Centessa Pharmaceuticals plc (CNTA)
CIK:        0001847903
Form:       8-K
Filed at:   2022-10-06T23:59:59+00:00
Accession:  0001193125-22-258932
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Centessa files corrected Articles of Association; no change to share structure or rights
--------------------------------------------------------------------------------

- Corrected Articles of Association adopted May 2021, effective June 2021, filed with UK Registrar.
- Articles authorize issuance of unlimited ordinary shares and unlimited deferred shares.
- Filing is procedural; no impact on business operations or financial results.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847903/000119312522258932/0001193125-22-258932-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847903/000119312522258932/d378676d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-258932

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer